Case Report

Resolution of Periodic Breathing in a Child with Idiopathic Pulmonary Arterial Hypertension

Table 1

PSG results of the patient before and after treprostinil and oxygen therapy.

ResultsAt diagnosisAfter treprostinil

TST, min338269.5
Sleep latency, min11.46.4
Sleep efficiency, %67.370.8
REM latency, min276.5136.5
Stage N1, %TST24.97.4
Stage N2, %TST4657
Stage N3, %TST24.428.2
REM, %TST4.77.4
Arousals, total index23.19.1
Mean sleep SpO2 (%)9395
Minimum SpO2 (%)5790
Desaturation Index (events/hr)15.70.5
Highest TcCO2/etCO2 (mmHg)4546
Mean TcCO2/etCO2 (mmHg)3239
OAHI (events/hour)00
CAHI (events/hour)6.30.5
RVSP (estimated)Suprasystemic<1/2 systemic
NT-proBNP (pmol/L)14712
6MWT (meters)380660
Mean SpO2 during wakefulness (%)9499
Mean TcCO2/etCO2 during wakefulness (%)3035

TST: total sleep time, REM: rapid eye movements, SaO2: oxygen saturation, TcCO2: transcutaneous carbon dioxide, etCO2: end tidal carbon dioxide, OAHI: obstructive apnea-hypopnea index, CAHI: central apnea-hypopnea index, RVSP: right ventricular systolic pressure, NT-proBNP: N-terminal pro b-type natriuretic peptide, and6MWT: 6-minute walk test.